"My scene was supposed to be funny, and it got nothing in the f---ing Chinese Theatre," the comedian says while discussing ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

India's anti-obesity drug market is valued at Rs 3,000-3,500 crore and is projected to grow nearly eightfold to Rs 25,000 ...

Researchers in a recent study discovered that people taking medications to help them lose weight might experience weight gain ...

Editors: Story has been updated from original, with material from the president of the Arizona Obesity Organization. Slug: ...

A spokesperson said: “Results from the STEP trials demonstrate that weight regain is likely once medication is stopped.

Those projections of reduced spending were reflected in a survey released in December by data analytics firm Numerator that ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

A federal court ruled in Mylan's favor, finding no infringement of Novo's patent tied to Wegovy, rejecting direct, ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks.

China's Sciwind Biosciences is in talks with a U.S. company interested in licensing its experimental weight-loss drug for ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...